share

Crizotinib-D5 CAS NO 1395950-84-1


Unit Price:

CAS No.:1395950-84-1

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Crizotinib-D5 CAS NO 1395950-84-1 is a deuterated isotopologue of the targeted cancer therapy drug Crizotinib, where five hydrogen atoms are replaced with deuterium. This stable isotope-labeled compound is essential for use as an internal standard in quantitative bioanalytical methods, ensuring the highest accuracy and reliability in pharmacokinetic and metabolic studies. It is a critical tool for pharmaceutical R&D laboratories, contract research organizations (CROs), and academic institutions engaged in advanced drug development and clinical research for oncology treatments.

Application

  • Bioanalytical Internal Standard: Primary use as a deuterated internal standard in Liquid Chromatography-Mass Spectrometry (LC-MS/MS) for the precise quantification of Crizotinib in biological matrices (plasma, serum, tissue).
  • Drug Metabolism and Pharmacokinetics (DMPK): Facilitates accurate studies on absorption, distribution, metabolism, and excretion (ADME) of Crizotinib.
  • Clinical Research: Supports therapeutic drug monitoring (TDM) and pharmacokinetic analysis during clinical trials for non-small cell lung cancer (NSCLC) and other ALK-positive cancers.
  • Pharmaceutical Quality Control: Used in method development and validation to ensure the specificity and accuracy of assays for drug substance and product analysis.
  • Forensic and Doping Analysis: Applied in specialized testing protocols where precise identification and quantification of the parent drug are required.

Basic Information

Product Name Crizotinib-D5
CAS No. 1395950-84-1
Molecular Formula C21H17D5Cl2FN5O
Molecular Weight 450.36 g/mol (for C21H17D5Cl2FN5O)
Synonyms (R)-3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-amine-d5; PF-02341066-d5; Xalkori-d5; Crizotinib (phenyl-d5); Crizotinib-d5 (deuterated at the phenyl ring); Deuterated Crizotinib; Crizotinib Internal Standard; Crizotinib Stable Isotope.
EINECS Contact for details

Quality Control

Every batch of Crizotinib-D5 is manufactured and tested under strict quality management systems. We guarantee high chemical and isotopic purity, with comprehensive characterization by NMR, MS, and HPLC. A detailed Certificate of Analysis (COA) is provided with each shipment, confirming identity, purity (typically ≥98% by HPLC), isotopic enrichment (≥98 atom % D), and the absence of critical impurities. Our quality commitment supports compliance with GLP and GMP guidelines for research use.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below in a freezer. This product is hygroscopic (moisture-sensitive). Allow the sealed vial to equilibrate to room temperature before opening to minimize moisture absorption. For long-term storage, keep desiccated under an inert atmosphere.

Specification

Item Specification
Appearance White to off-white solid
Identification (IR) Conforms to structure
Identification (MS) Conforms to structure
Purity (HPLC) ≥ 98.0%
Isotopic Purity ≥ 98 atom % D
Chemical Purity (by NMR) Conforms
Water Content (KF) ≤ 1.0%
Residual Solvents (GC) Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.